Literature DB >> 10787224

The use of abusable prescription drugs: the role of gender.

L Simoni-Wastila1.   

Abstract

It is well documented that women face greater medical exposure to psychotropic drugs than do men, but little research examines whether women also have increased use of prescription drugs with abuse potential. The objectives were to examine gender differences in the use of abusable prescription drugs and to assess how use varies by gender and if patterns of use vary across therapeutic drug classes. With data from the 1987 National Medical Expenditures Survey (NMES), logistic regression analysis is used to model the influence of gender and other sociodemographic and diagnostic variables on the probability of drug use. Women are 48% more likely than men to use any abusable prescription drug, controlling for demographics, health status, economic status, and diagnosis. Additional analyses reveal that being female is a statistically significant predictor of anxiolytic and narcotic analgesic use but not of sedative-hypnotic or stimulant use. Marital status, age, urbanicity, employment status, and having a regular source of care explain gender differences in the use of abusable prescription drugs. Both healthcare and substance abuse treatment providers should be cognizant that women may have greater exposure to these potent prescription medicines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787224     DOI: 10.1089/152460900318470

Source DB:  PubMed          Journal:  J Womens Health Gend Based Med        ISSN: 1524-6094


  46 in total

1.  Risk factors associated with problem use of prescription drugs.

Authors:  Linda Simoni-Wastila; Gail Strickler
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

Review 2.  Age-related aspects of addiction.

Authors:  Birgit Koechl; Annemarie Unger; Gabriele Fischer
Journal:  Gerontology       Date:  2012-06-21       Impact factor: 5.140

3.  Age and gender trends in long-term opioid analgesic use for noncancer pain.

Authors:  Cynthia I Campbell; Constance Weisner; Linda Leresche; G Thomas Ray; Kathleen Saunders; Mark D Sullivan; Caleb J Banta-Green; Joseph O Merrill; Michael J Silverberg; Denise Boudreau; Derek D Satre; Michael Von Korff
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

4.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

5.  Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Authors:  Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

6.  Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: patterns, user characteristics, and management options.

Authors:  Meredith Y Smith; George Woody
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

7.  Correlates of nonmedical use of prescription benzodiazepine anxiolytics: results from a national survey of U.S. college students.

Authors:  Sean Esteban McCabe
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

8.  Medical and nonmedical use of prescription drugs among secondary school students.

Authors:  Sean Esteban McCabe; Carol J Boyd; Amy Young
Journal:  J Adolesc Health       Date:  2006-10-05       Impact factor: 5.012

9.  Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005.

Authors:  Stephen M Thielke; Linda Simoni-Wastila; Mark J Edlund; Andrea DeVries; Bradley C Martin; Jennifer B Braden; Ming-Yu Fan; Mark D Sullivan
Journal:  Pain Med       Date:  2009-11-25       Impact factor: 3.750

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.